| Plural | floxuridines |
floxuridine injection
floxuridine injektion
intra-arterial floxuridine
intraarteriel floxuridine
floxuridine infusion
floxuridine infusion
floxuridine therapy
floxuridine terapi
hepatic floxuridine
hepatiske floxuridine
floxuridine administration
floxuridine administration
floxuridine treatment
floxuridine behandling
topical floxuridine
topisk floxuridine
intravenous floxuridine
intravenøs floxuridine
floxuridine is commonly administered via hepatic arterial infusion for liver cancer treatment.
Floxuridin administreres ofte via hepatisk arteriel infusionsbehandling til behandling af levercancer.
the recommended floxuridine dosage varies based on the patient's body surface area.
Den anbefalede floxuridindosis varierer afhængigt af patientens kropsoverfladeareal.
floxuridine chemotherapy may cause severe myelosuppression in some patients.
Floxuridinkemoterapi kan forårsage alvorlig myelosuppression hos nogle patienter.
physicians must monitor floxuridine toxicity levels during treatment.
Læger skal overvåge floxuridintoxicitetsniveauer under behandling.
floxuridine infusion is typically given over several hours.
Floxuridininfusionen gives typisk over flere timer.
clinical trials have shown floxuridine effectiveness in treating metastatic colorectal cancer.
Kliniske forsøg har vist floxuridins effektivitet ved behandling af metastatisk tykkelæbekræft.
patients receiving floxuridine therapy require regular blood count monitoring.
Patienter, der modtager floxuridinbehandling, kræver regelmæssig blodtællingsovervågning.
floxuridine metabolism occurs primarily in the liver.
Floxuridinmetabolismer sker primært i leveren.
the side effects of floxuridine include nausea, vomiting, and diarrhea.
De bivirkninger af floxuridin inkluderer kvalme, opkast og diaré.
floxuridine can be combined with other chemotherapeutic agents for enhanced efficacy.
Floxuridin kan kombineres med andre kemoterapeutiske lægemidler for forbedret effektivitet.
healthcare providers should explain floxuridine risks before initiating treatment.
Sundhedsplejepersonale bør forklare risikoen ved floxuridin før behandling begynder.
floxuridine hepatic arterial infusion delivers the drug directly to liver tumors.
Floxuridin hepatisk arteriel infusionsbehandling leverer lægemedlet direkte til lever tumorer.
floxuridine injection
floxuridine injektion
intra-arterial floxuridine
intraarteriel floxuridine
floxuridine infusion
floxuridine infusion
floxuridine therapy
floxuridine terapi
hepatic floxuridine
hepatiske floxuridine
floxuridine administration
floxuridine administration
floxuridine treatment
floxuridine behandling
topical floxuridine
topisk floxuridine
intravenous floxuridine
intravenøs floxuridine
floxuridine is commonly administered via hepatic arterial infusion for liver cancer treatment.
Floxuridin administreres ofte via hepatisk arteriel infusionsbehandling til behandling af levercancer.
the recommended floxuridine dosage varies based on the patient's body surface area.
Den anbefalede floxuridindosis varierer afhængigt af patientens kropsoverfladeareal.
floxuridine chemotherapy may cause severe myelosuppression in some patients.
Floxuridinkemoterapi kan forårsage alvorlig myelosuppression hos nogle patienter.
physicians must monitor floxuridine toxicity levels during treatment.
Læger skal overvåge floxuridintoxicitetsniveauer under behandling.
floxuridine infusion is typically given over several hours.
Floxuridininfusionen gives typisk over flere timer.
clinical trials have shown floxuridine effectiveness in treating metastatic colorectal cancer.
Kliniske forsøg har vist floxuridins effektivitet ved behandling af metastatisk tykkelæbekræft.
patients receiving floxuridine therapy require regular blood count monitoring.
Patienter, der modtager floxuridinbehandling, kræver regelmæssig blodtællingsovervågning.
floxuridine metabolism occurs primarily in the liver.
Floxuridinmetabolismer sker primært i leveren.
the side effects of floxuridine include nausea, vomiting, and diarrhea.
De bivirkninger af floxuridin inkluderer kvalme, opkast og diaré.
floxuridine can be combined with other chemotherapeutic agents for enhanced efficacy.
Floxuridin kan kombineres med andre kemoterapeutiske lægemidler for forbedret effektivitet.
healthcare providers should explain floxuridine risks before initiating treatment.
Sundhedsplejepersonale bør forklare risikoen ved floxuridin før behandling begynder.
floxuridine hepatic arterial infusion delivers the drug directly to liver tumors.
Floxuridin hepatisk arteriel infusionsbehandling leverer lægemedlet direkte til lever tumorer.
Udforsk ofte søgte ordforråd
Vil du lære ordforråd mere effektivt? Download DictoGo-appen og få glæde af flere funktioner til at huske og gennemgå ordforråd!
Download DictoGo nu